168 related articles for article (PubMed ID: 16606761)
1. Emerging pharmacotherapies for Creutzfeldt-Jakob disease.
Korth C; Peters PJ
Arch Neurol; 2006 Apr; 63(4):497-501. PubMed ID: 16606761
[TBL] [Abstract][Full Text] [Related]
2. Human prion diseases: molecular and clinical aspects.
Glatzel M; Stoeck K; Seeger H; Lührs T; Aguzzi A
Arch Neurol; 2005 Apr; 62(4):545-52. PubMed ID: 15824251
[TBL] [Abstract][Full Text] [Related]
3. [New knowledge about Creutzfeldt-Jakob disease can yield therapeutic possibilities].
Stølsmark T; Tysnes OB
Tidsskr Nor Laegeforen; 2010 Mar; 130(6):601-4. PubMed ID: 20349004
[TBL] [Abstract][Full Text] [Related]
4. Curative properties of antibodies against prion protein: a comparative in vitro study of monovalent fragments and divalent antibodies.
Alexandrenne C; Hanoux V; Dkhissi F; Boquet D; Couraud JY; Wijkhuisen A
J Neuroimmunol; 2009 Apr; 209(1-2):50-6. PubMed ID: 19232746
[TBL] [Abstract][Full Text] [Related]
5. Creutzfeldt-Jakob disease and inclusion body myositis: abundant disease-associated prion protein in muscle.
Kovacs GG; Lindeck-Pozza E; Chimelli L; Araújo AQ; Gabbai AA; Ströbel T; Glatzel M; Aguzzi A; Budka H
Ann Neurol; 2004 Jan; 55(1):121-5. PubMed ID: 14705121
[TBL] [Abstract][Full Text] [Related]
6. Mouse-adapted sporadic human Creutzfeldt-Jakob disease prions propagate in cell culture.
Lawson VA; Vella LJ; Stewart JD; Sharples RA; Klemm H; Machalek DM; Masters CL; Cappai R; Collins SJ; Hill AF
Int J Biochem Cell Biol; 2008; 40(12):2793-801. PubMed ID: 18590830
[TBL] [Abstract][Full Text] [Related]
7. Analysis of prion strains by PrPSc profiling in sporadic Creutzfeldt-Jakob disease.
Schoch G; Seeger H; Bogousslavsky J; Tolnay M; Janzer RC; Aguzzi A; Glatzel M
PLoS Med; 2006 Feb; 3(2):e14. PubMed ID: 16354106
[TBL] [Abstract][Full Text] [Related]
8. Prion deposition in olfactory biopsy of sporadic Creutzfeldt-Jakob disease.
Tabaton M; Monaco S; Cordone MP; Colucci M; Giaccone G; Tagliavini F; Zanusso G
Ann Neurol; 2004 Feb; 55(2):294-6. PubMed ID: 14755736
[TBL] [Abstract][Full Text] [Related]
9. Update on Creutzfeldt-Jakob disease.
Mallucci G; Collinge J
Curr Opin Neurol; 2004 Dec; 17(6):641-7. PubMed ID: 15542971
[TBL] [Abstract][Full Text] [Related]
10. The sympathetic nervous system is involved in variant Creutzfeldt-Jakob disease.
Haïk S; Faucheux BA; Sazdovitch V; Privat N; Kemeny JL; Perret-Liaudet A; Hauw JJ
Nat Med; 2003 Sep; 9(9):1121-3. PubMed ID: 12937415
[TBL] [Abstract][Full Text] [Related]
11. Molecular types of Creutzfeldt-Jakob disease: the strange diversity of prions.
Bosque P
Neurology; 2005 Nov; 65(10):1520-1. PubMed ID: 16301475
[No Abstract] [Full Text] [Related]
12. Recent developments in prion immunotherapy.
Heppner FL; Aguzzi A
Curr Opin Immunol; 2004 Oct; 16(5):594-8. PubMed ID: 15342005
[TBL] [Abstract][Full Text] [Related]
13. Prions: proof of proteinaceous nature but problems with population polymorphisms.
Griffiths PD
Rev Med Virol; 2004; 14(6):341-3. PubMed ID: 15495195
[No Abstract] [Full Text] [Related]
14. Dilated cardiomyopathy and Creutzfeldt-Jakob disease: evidence for a role of cellular prion protein in the heart?
Bianchin MM; Walz R; Brentani RR; Martins VR
Arch Intern Med; 2005 Jul; 165(14):1663-4. PubMed ID: 16043687
[No Abstract] [Full Text] [Related]
15. Novel prion protein conformation and glycotype in Creutzfeldt-Jakob disease.
Zanusso G; Polo A; Farinazzo A; Nonno R; Cardone F; Di Bari M; Ferrari S; Principe S; Gelati M; Fasoli E; Fiorini M; Prelli F; Frangione B; Tridente G; Bentivoglio M; Giorgi A; Schininà ME; Maras B; Agrimi U; Rizzuto N; Pocchiari M; Monaco S
Arch Neurol; 2007 Apr; 64(4):595-9. PubMed ID: 17420324
[TBL] [Abstract][Full Text] [Related]
16. Utility of RNAi-mediated prnp gene silencing in neuroblastoma cells permanently infected by prions: potentials and limitations.
Kim Y; Han B; Titlow W; Mays CE; Kwon M; Ryou C
Antiviral Res; 2009 Nov; 84(2):185-93. PubMed ID: 19748523
[TBL] [Abstract][Full Text] [Related]
17. Adenosine A1 receptor protein levels and activity is increased in the cerebral cortex in Creutzfeldt-Jakob disease and in bovine spongiform encephalopathy-infected bovine-PrP mice.
Rodríguez A; Martín M; Albasanz JL; Barrachina M; Espinosa JC; Torres JM; Ferrer I
J Neuropathol Exp Neurol; 2006 Oct; 65(10):964-75. PubMed ID: 17021401
[TBL] [Abstract][Full Text] [Related]
18. The cellular prion protein: biochemistry, topology, and physiologic functions.
Griffoni C; Toni M; Spisni E; Bianco M; Santi S; Riccio M; Tomasi V
Cell Biochem Biophys; 2003; 38(3):287-304. PubMed ID: 12794269
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic interventions ameliorating prion disease.
Brazier MW; Wall VA; Brazier BW; Masters CL; Collins SJ
Expert Rev Anti Infect Ther; 2009 Feb; 7(1):83-105. PubMed ID: 19622059
[TBL] [Abstract][Full Text] [Related]
20. Hybrid molecules synergistically acting against protein aggregation diseases.
Korth C; Klingenstein R; Müller-Schiffmann A
Curr Top Med Chem; 2013; 13(19):2484-90. PubMed ID: 24059335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
